A. Danek et al., DECREASE IN ANDROGEN-BINDING AND EFFECT OF ANDROGEN TREATMENT IN A CASE OF X-LINKED BULBOSPINAL NEURONOPATHY, The Clinical investigator, 72(11), 1994, pp. 892-897
X-linked recessive bulbospinal neuronopathy is a motoneuron disorder t
o be distinguished from amyotrophic lateral sclerosis. Effective treat
ment is not known. Patients with X-linked recessive bulbospinal neuron
opathy may show gynecomastia and testicular atrophy, and a mutation in
the androgen receptor gene has been found associated with the disease
. Intermediate steps leading from the androgen receptor abnormality to
the clinical syndrome have not yet been elucidated. Therefore, bindin
g of androgen ([H-3]dihydro-testosterone) to its specific receptor by
genital skin fibroblasts cultured from a patient with X-linked recessi
ve bulbospinal neuronopathy and confirmed androgen receptor mutation w
as studied. Markedly decreased binding capacity was found. We treated
the patient for 6 months with nandrolone-decanoate. No effect on his n
euromuscular status was observed during 2 years of follow-up.